The Dallas-based HCA hospitals will have immediate, local access to hundreds of complex tests performed by med fusion.

The purpose of the contract is to further HCA’s goal of expediting specific test results, which have in the past taken longer because of transportation.

The partnering organisations predict that the new agreement will help to lower healthcare costs and create additional jobs in the Dallas area, giving a boost to the local economy.

med fusion CEO Keith Laughman said that they are pleased to work with an organisation of HCA’s caliber and look forward to supporting its patient care goals and this agreement will allow med fusion to deliver HCA’s patients with critical test results more quickly, which makes care more efficient, and enable doctors to start treatment sooner.

Texas-based med fusion is an integrated laboratory and clinical trials service organisation providing support to healthcare providers, biotech and pharmaceutical companies, through a patient-centric support model.